Nam-Su Lee

Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea

Eui‐Kyung Lee, Cédric Révil, C.A. Ngoh et al. · Clinical Therapeutics · 2012 · 18 citations

Medicine, Oncology, Pharmacoeconomics +12

Solitary Extramedullary Plasmacytoma of the Liver without Systemic Monoclonal Gammopathy

Jong-Ho Won, Hyun Jung Kim, Sang Byung Bae et al. · Journal of Korean Medical Science · 2007 · 16 citations · Full text

Medicine, Oncology, Pathology +16

Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor

Seock‐Ah Im, Sung‐Bae Kim, Moon Lee et al. · Oncology Reports · 2005 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16